-       Report 
   - October 2025
    -  198 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - May 2023
    -  96 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                      Fetal Alcohol Syndrome (FAS) Drugs are a type of Central Nervous System (CNS) Drugs used to treat the physical and mental effects of prenatal alcohol exposure. These drugs are used to reduce the severity of physical and mental disabilities caused by FAS, such as facial deformities, growth deficiencies, and cognitive and behavioral problems. FAS Drugs are typically prescribed to pregnant women and infants, and may include medications to treat seizures, anxiety, and depression.
FAS Drugs are a    relatively new class of CNS Drugs, and research is ongoing to develop more effective treatments. Currently, there are no approved drugs specifically for FAS, but some medications used to treat other CNS conditions may be used off-label to treat FAS.
Some companies in the Fetal Alcohol Syndrome Drugs market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less   Read more